Clinical Trial Update: A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. [Phase 2]

View source ↗

Summary

A Phase 2 mechanistic trial is investigating the effects of dapagliflozin alone or with balcinrenone on body fluid and electrolyte handling and energy metabolis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Balcinrenone
• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Klinikum Nürnberg | Conditions: Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis | Phase 2 | Status: RECRUITING